Who is a candidate for weight loss drugs
These 3.8 million Part D enrollees met the clinical criteria, did not have a diagnosis of type 2 diabetes, OSA, or MASH, or a GLP-1 Part D-covered prescription in 2023, and could be eligible for the Medicare GLP-1 Bridge, assuming no changes in diagnosis or GLP-1 use in Part D in 2026
Start your intake Why Semaglutide Causes Stomach Pain and Nausea Semaglutide works by slowing stomach emptying and signaling fullness to your brain's hunger centers
Many patients do not give up on their obesity treatment journey, even if they need to stop their initial medication, said Dr
Push notifications time reminders around meals and walks, so you hit macronutrient and hydration targets that protect muscle and digestion while using a GLP-1 medication